PubMed

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Miller J, Chan BK, Nelson HD.

Ann Intern Med. 2002 May 7;136(9):680-90. Review. Erratum in: Ann Intern Med. 2003 Feb 18;138(4):360.. PMID: 11992304 [PubMed - indexed for MEDLINE]Related articlesFree article

Postmenopausal hormone replacement therapy: scientific review.

Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

JAMA. 2002 Aug 21;288(7):872-81. Review.PMID: 12186605 [PubMed - indexed for MEDLINE]Related articlesFree article

Hormone replacement therapy and cognition: systematic review and meta-analysis.

LeBlanc ES, Janowsky J, Chan BK, Nelson HD.

JAMA. 2001 Mar 21;285(11):1489-99. Review.PMID: 11255426 [PubMed - indexed for MEDLINE]Related articlesFree article

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY.

BMJ. 2008 May 31;336(7655):1227-31. Epub 2008 May 20. Review.PMID: 18495631 [PubMed - indexed for MEDLINE]Related articlesFree article

Postmenopausal hormone replacement therapy and venous thromboembolism.

Wu O.

Gend Med. 2005;2 Suppl A:S18-27. Review.PMID: 16551553 [PubMed - indexed for MEDLINE]Related articles

Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis.

Shah NR, Borenstein J, Dubois RW.

Menopause. 2005 Nov-Dec;12(6):668-78. Review.PMID: 16278609 [PubMed - indexed for MEDLINE]Related articlesFree article

Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.

Nelson HD.

JAMA. 2004 Apr 7;291(13):1610-20. Review.PMID: 15069049 [PubMed - indexed for MEDLINE]Related articlesFree article

Breast cancer risk with postmenopausal hormonal treatment.

Collins JA, Blake JM, Crosignani PG.

Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331. PMID: 16150813 [PubMed - indexed for MEDLINE]Related articlesFree article

[From the Cochrane Library: postmenopausal hormone replacement therapy (HRT) does not protect women against cardiovascular disease but does lead to an increased risk of venous thromboembolism]

Hamerlynck JV, Middeldorp S, Scholten RJ.

Ned Tijdschr Geneeskd. 2006 Mar 11;150(10):546-8. Dutch. PMID: 16566418 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Postmenopausal estrogen replacement therapy and the risk for blood clots: a review from the U.S. Preventive Services Task Force.

[No authors listed]

Ann Intern Med. 2002 May 7;136(9):I42. No abstract available. PMID: 11992323 [PubMed - indexed for MEDLINE]Related articlesFree article

Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease.

Humphrey LL, Chan BK, Sox HC.

Ann Intern Med. 2002 Aug 20;137(4):273-84. Review.PMID: 12186518 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.

Oger E, Scarabin PY.

Drugs Aging. 1999 Jan;14(1):55-61. Review.PMID: 10069408 [PubMed - indexed for MEDLINE]Related articles

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.

Pérez Gutthann S, García Rodríguez LA, Castellsague J, Duque Oliart A.

BMJ. 1997 Mar 15;314(7083):796-800.PMID: 9081000 [PubMed - indexed for MEDLINE]Related articlesFree article

Postmenopausal hormone therapy: cardiovascular risks.

[No authors listed]

Prescrire Int. 2003 Apr;12(64):65-9.PMID: 12674130 [PubMed - indexed for MEDLINE]Related articles

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.

Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF.

Arch Intern Med. 1997 Jul 28;157(14):1522-30. Review.PMID: 9236553 [PubMed - indexed for MEDLINE]Related articles

Hormone replacement therapy for cognitive function in postmenopausal women.

Hogervorst E, Yaffe K, Richards M, Huppert F.

Cochrane Database Syst Rev. 2002;(3):CD003122. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD003122. PMID: 12137675 [PubMed - indexed for MEDLINE]Related articles

Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.

Shapiro S.

Climacteric. 2006 Dec;9(6):416-20.PMID: 17085373 [PubMed - indexed for MEDLINE]Related articles

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D; HERS Research Group.

JAMA. 2002 Jul 3;288(1):58-66.PMID: 12090863 [PubMed - indexed for MEDLINE]Related articlesFree article

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY.

Cochrane Database Syst Rev. 2006 Jul 19;3:CD005326. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD005326. PMID: 16856092 [PubMed - indexed for MEDLINE]Related articles

Validation of a decision model for preventive pharmacological strategies in postmenopausal women.

Perreault S, Levinton C, Laurier C, Moride Y, Ste-Marie LG, Crott R.

Eur J Epidemiol. 2005;20(1):89-101.PMID: 15756909 [PubMed - indexed for MEDLINE]Related articles